AGTC Ventures
AGTC Ventures
  • Home
  • About
    • About Us
    • Services
    • Bio Revolution
  • Clients
    • Current Clients
    • Previous Clients
    • Job Openings
    • PatentSeek
  • Events
    • Partner Events
    • Podcasts/Webinars
    • BIO - RESI Boston 2025
  • News
  • Contact Us
  • More
    • Home
    • About
      • About Us
      • Services
      • Bio Revolution
    • Clients
      • Current Clients
      • Previous Clients
      • Job Openings
      • PatentSeek
    • Events
      • Partner Events
      • Podcasts/Webinars
      • BIO - RESI Boston 2025
    • News
    • Contact Us
  • Sign In
  • Create Account

  • My Account
  • Signed in as:

  • filler@godaddy.com


  • My Account
  • Sign out

Signed in as:

filler@godaddy.com

  • Home
  • About
    • About Us
    • Services
    • Bio Revolution
  • Clients
    • Current Clients
    • Previous Clients
    • Job Openings
    • PatentSeek
  • Events
    • Partner Events
    • Podcasts/Webinars
    • BIO - RESI Boston 2025
  • News
  • Contact Us

Account


  • My Account
  • Sign out


  • Sign In
  • My Account

Synthetic Biology & Artificial Intelligence: An Emerging Bioeconomy Revolution

Check out the some of these interesting videos as well as the News items links full of information on cutting edge biotech, gene editing, cell and gene therapy, mRNA and AI tech. 

Learn More

Great video from Illumina Inc. 


 "Envisioning how genomics will improve human health"

From Gene Therapy to Resurrecting the Wooly Mammoth and "Designer Babies"

If James Watson is the Grandfather, then George Church is the Father of Genomics. An unstoppable force of nature for 30+ years at Harvard

The Science and Ethics of Genome Editing

Jennifer Doudna (Mammoth Biosciences,  Scribe Therapeutics, Nobel Laureaute for CRISPR gene editing contributions) talks about ethical considerations impacting genome engineering

E.O. Wilson on convergence of AI, Synthetic Biology, Robotics


"Synthetic Biology Will Radically Change the World"

HIV Therapy R&D at American Gene Technologies

Jeff Galvin is a Harvard grad retired Silicon Valley exec computing tecchie who returned to biotech as CEO of American Gene Technologies. 


See Also :  

CRISPR-Cas13d Nuclease System Effectively Inhibits HIV-1 in Vitro and Base Editing Slams the door shut on HIV

Can we cure genetic diseases by rewriting DNA

 David R. Liu shares a breakthrough: his lab's development of base editors that can rewrite DNA. 

CRISPR in Context: A New World of Human Genetic Engineering

Genetic Engineering and Ethics "CRISPR in Context"  

Genetic Engineering Will Change Everything Forever – CRISPR

The impact of genetic engineering tools like "CRISPR"  to the Human Genome of the future


Copyright © 2025 AGTC Ventures LLC - All Rights Reserved.

  • Home
  • About Us
  • Services
  • Job Openings
  • PatentSeek
  • Partner Events
  • News
  • Contact Us

Powered by

Take the first step to your business launch

Send us a message and PDF format pitch deck (if applicable). If you don't have one that's okay, that's what we're here for. 

Contact Us